#licensing

Candidate metadata indicates the US is using AI to improve the speed and accuracy of nuclear technology licensing applications, pointing to a notable shift in how advanced energy projects may be reviewed.

Biopharma companies are restructuring international licensing agreements to reduce their exposure to Most Favored Nation pricing rules, which link US drug prices to the lowest prices paid in other countries.